Elite Pharmaceuticals, Inc. (ELI) Awarded Second U.S. Patent for Abuse Resistant Drug Formulation
4/23/2013 11:21:05 AM
More...
|
Elite Pharmaceuticals, Inc. (ELI) Announces First Shipment of Generic Phentermine Capsules
4/11/2013 12:08:54 PM
More...
|
Elite Pharmaceuticals, Inc. (ELI) Announces First Shipments From Expanded 15,000 Square Foot Facility
1/28/2013 9:05:10 AM
More...
|
Elite Pharmaceuticals, Inc. (ELI) Announces Agreement for Supply of Phentermine Active Ingredient
12/13/2012 9:46:53 AM
More...
|
Elite Pharmaceuticals, Inc. (ELI) Announces Amendment to Bridge Loan Facility
12/10/2012 9:09:09 AM
More...
|
Elite Pharmaceuticals, Inc. (ELI) Reports Financial Results for the Second Quarter of Fiscal 2013
11/15/2012 7:46:52 AM
More...
|
Elite Pharmaceuticals, Inc. (ELI) Announces First Shipment of Generic Phendimetrazine Tablet Product
11/15/2012 7:36:44 AM
More...
|
Elite Pharmaceuticals, Inc. (ELI) Announces Fiscal Year 2013 Second Quarter Investor Conference Call on Thursday, November 15, 2012
11/13/2012 12:31:12 PM
More...
|
Elite Pharmaceuticals, Inc. (ELI) Announces Approval of Phentermine Capsules and Delayed Launch
10/15/2012 7:38:05 AM
More...
|
Elite Pharmaceuticals, Inc. (ELI) Announces Renewed Manufacturing and Supply Agreement With ThePharmaNetwork, LLC
9/28/2012 10:17:25 AM
More...
|
|